Suppr超能文献

应用中心复合设计优化含 L-DOPA 的 PLGA 纳米粒制剂。

Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.

机构信息

Drug Delivery Research Unit, School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

出版信息

Drug Dev Ind Pharm. 2013 Feb;39(2):321-30. doi: 10.3109/03639045.2012.681054. Epub 2012 May 21.

Abstract

The aim of this work was to prepare L-DOPA loaded poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles by a modified water-in-oil-in-water (W(1)/O/W(2)) emulsification solvent evaporation method. A central composite design was applied for optimization of the formulation parameters and for studying the effects of three independent variables: PLGA concentration, polyvinyl alcohol (PVA) concentration and organic solvent removal rate on the particle size and the entrapment efficiency (response variables). Second-order models were obtained to adequately describe the influence of the independent variables on the selected responses. The analysis of variance showed that the three independent variables had significant effects (p < 0.05) on the responses. The experimental results were in perfect accordance with the predictions estimated by the models. Using the desirability approach and overlay contour plots, the optimal preparation area can be highlighted. It was found that the optimum values of the responses could be obtained at higher concentration of PLGA (5%, w/v) and PVA (6%, w/v); and faster organic solvent removal rate (700 rpm). The corresponding particle size was 256.2 nm and the entrapment efficiency was 62.19%. FTIR investigation confirmed that the L-DOPA and PLGA polymer maintained its backbone structure in the fabrication of nanoparticles. The scanning electron microscopic images of nanoparticles showed that all particles had spherical shape with porous outer skin. The results suggested that PLGA nanoparticles might represent a promising formulation for brain delivery of L-DOPA. The preparation of L-DOPA loaded PLGA nanoparticles can be optimized by the central composite design.

摘要

本工作旨在通过改良的 W(1)/O/W(2)乳化溶剂挥发法制备载 L-多巴的聚(D,L-丙交酯-co-乙交酯)(PLGA)纳米粒。采用中心复合设计对制剂参数进行优化,并研究三个独立变量(PLGA 浓度、聚乙烯醇(PVA)浓度和有机溶剂去除率)对粒径和包封效率(响应变量)的影响。得到了二阶模型,以充分描述独立变量对所选响应的影响。方差分析表明,三个独立变量对响应有显著影响(p<0.05)。实验结果与模型预测完全吻合。使用适宜性方法和叠加等高线图,可以突出最佳制备区域。结果发现,在较高浓度的 PLGA(5%,w/v)和 PVA(6%,w/v)和较快的有机溶剂去除率(700 rpm)下,可获得响应的最佳值。相应的粒径为 256.2nm,包封效率为 62.19%。FTIR 研究证实,L-多巴和 PLGA 聚合物在纳米粒的制备过程中保持其骨架结构。纳米粒的扫描电子显微镜图像表明,所有颗粒均具有多孔外皮的球形形状。结果表明,PLGA 纳米粒可能是 L-多巴脑内递药的一种有前途的制剂。可以通过中心复合设计优化载 L-多巴的 PLGA 纳米粒的制备。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验